We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » FDA Denies Agreement Will Cause Burdens For Personalized Medicine
FDA Denies Agreement Will Cause Burdens For Personalized Medicine
May 5, 2006
International efforts between the U.S., the European Union and Japan to standardize industry submission and agency review of genomic data will move personalized medicine forward without increasing regulatory burdens, a high-ranking FDA official says.